These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4033540)

  • 1. Comparison of stage IV and IV-S neuroblastoma in the first year of life.
    Nickerson HJ; Nesbit ME; Grosfeld JL; Baehner RL; Sather H; Hammond D
    Med Pediatr Oncol; 1985; 13(5):261-8. PubMed ID: 4033540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Kaneko M; Tsuchida Y; Uchino J; Takeda T; Iwafuchi M; Ohnuma N; Mugishima H; Yokoyama J; Nishihira H; Nakada K; Sasaki S; Sawada T; Kawa K; Nagahara N; Suita S; Sawaguchi S
    J Pediatr Hematol Oncol; 1999; 21(3):190-7. PubMed ID: 10363851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
    Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
    J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of therapy in stage IV-S neuroblastoma with massive hepatomegaly.
    Blatt J; Deutsch M; Wollman MR
    Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1467-71. PubMed ID: 3624025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage 4S neuroblastoma, a disseminated tumor with excellent outcome.
    Elimam NA; Atra AA; Fayea NY; Al-Asaad TG; Khattab TM; Al-Sulami GA; Felimban SK
    Saudi Med J; 2006 Nov; 27(11):1734-6. PubMed ID: 17106552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival in neuroblastoma using multimodality therapy.
    Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Vawter G; Sallan SE
    Radiother Oncol; 1984 Oct; 2(3):189-200. PubMed ID: 6441972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
    Feng C; Tang SQ; Wang JW; Liu Y; Yang G
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):885-7. PubMed ID: 20113653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of advanced neuroblastoma in children].
    Mutz I
    Wien Med Wochenschr; 1982 Jul; 132(13-14):325-8. PubMed ID: 6182700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan.
    Tsuchida Y; Yokoyama J; Kaneko M; Uchino J; Iwafuchi M; Makino S; Matsuyama S; Takahashi H; Okabe I; Hashizume K
    J Pediatr Surg; 1992 May; 27(5):616-22. PubMed ID: 1625134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of catecholamine metabolites, mIBG scan, and bone marrow cytology as response markers in stage 4 neuroblastoma.
    Hero B; Hunneman DH; Gahr M; Berthold F
    Med Pediatr Oncol; 2001 Jan; 36(1):220-3. PubMed ID: 11464889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
    Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
    J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group].
    Kremens B; Philip T; Bernard JL; Zucker JM
    Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage IV-S neuroblastoma: a study of 34 cases treated between 1982 and 1987.
    Suarez A; Hartmann O; Vassal G; Giron A; Habrand JL; Valteau D; Brugieres L; Kalifa C; Lemerle J
    Med Pediatr Oncol; 1991; 19(6):473-7. PubMed ID: 1961134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is extensive surgery required for treatment of advanced neuroblastoma?
    Kaneko M; Ohakawa H; Iwakawa M
    J Pediatr Surg; 1997 Nov; 32(11):1616-9. PubMed ID: 9396539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital, Nairobi.
    Kitonyi GW; Macharia WM; Mwanda OW; Pamnani R
    East Afr Med J; 2009 Dec; 86(12 Suppl):S39-46. PubMed ID: 21591508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma.
    Cheung NV; Heller G
    J Clin Oncol; 1991 Jun; 9(6):1050-8. PubMed ID: 2033419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.